Status:
NO_LONGER_AVAILABLE
Expanded Access for BLZ-100 (Tozuleristide)
Lead Sponsor:
Blaze Bioscience Inc.
Brief Summary
This is the Blaze Bioscience expanded access program for its investigational drug tozuleristide intended for patients with life-threatening diseases or conditions who have exhausted approved treatment...
Detailed Description
1. Contact Information: A licensed treating physician may submit questions or requests on behalf of a patient regarding expanded access to tozuleristide to be evaluated in accordance with Blaze Biosci...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Undergoing surgery for suspected or confirmed tumor
- Not eligible for current clinical trials of tozuleristide
Exclusion
Key Trial Info
Start Date :
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04343274
Last Update
April 4 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.